Free Submission Public Relations &
Deutsch English

OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide

BRIC OTC pharmaceuticals market: $30 billion industry estimated during 2012

Print article Print article
2014-01-29 05:55:02 - OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide - a new market research report on

Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the OTC pharmaceuticals industry and had a total market value of $29,595.5 million in 2012. Brazil was the fastest growing country with a CAGR of 12.7% over the 2008-12 period.

Within the OTC pharmaceuticals industry, China is the leading country among the BRIC nations with market revenues of $15,615.7 million in 2012. This was followed by Russia, Brazil and India with a value of $6,373.7, $5,771.9, and $1,834.2 million, respectively.

China is expected to lead the OTC pharmaceuticals industry in the BRIC nations with a value of $21,948.0 million in 2017, followed by Brazil, Russia, India with expected values of $9,908.9, $9,105.6 and $2,913.5 million, respectively.

Click for



report details: ..

Browse all Healthcare and Medical Market Research Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Mike King
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact